Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.64
-0.28 (-0.97%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
32
33
Next >
Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030
February 09, 2023
The Europe liver cancer therapeutics size was valued at US$ 384 million in 2022 and is estimated to reach US$ 627 million by 2030, growing at a CAGR of 8.95% during the forecast period (2023-2030)
Via
SBWire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 09, 2023
From
Pfizer Inc.
Via
Business Wire
Musculoskeletal Diseases Treatment Market Is Poised to Cross at High CAGR of 4.9% in 2023-2030
February 08, 2023
The Musculoskeletal Diseases Treatment Market size was valued at US$ YY million in 2023 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 4.8% during the forecast period...
Via
SBWire
Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.
February 08, 2023
Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
Via
SBWire
Capturing the U.S. Health Care Space with XLV
January 23, 2023
Via
Get News
Topics
ETFs
Exposures
COVID-19
Active Pharmaceutical Ingredients Market May Set Epic Growth Story : Pfizer, Novartis, Sanofi
February 07, 2023
Stay up-to-date with Active Pharmaceutical Ingredients Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Topics
Death
Exposures
Death
Biosimilars Market 2023 Industry Size, Share, Growth and Analysis by Demand, Opportunity, Key Players, Regional Development and Forecast 2029
February 03, 2023
Biosimilars Market Size, Share and Forecast 2023-2029 Key Players are – Samsung Biologics, Intas Pharmaceuticals Ltd, Celltrion, Reliance Life Sciences, Pfizer, Coherus BioSciences, Amgen, Biocon Ltd
Via
SBWire
Topics
Intellectual Property
Exposures
Intellectual Property
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
February 02, 2023
Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023?
Via
MarketBeat
Topics
ETFs
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
Pfizer Stock: What the Bulls and Bears are Getting Wrong
February 01, 2023
Pfizer stock is bouncing up and down after mixed Q4 earnings. There's been an emotional battle between bulls and bears but it's time for both to get rational
Via
MarketBeat
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
January 31, 2023
From
Pfizer Inc.
Via
Business Wire
MarketBeat Week in Review – 1/23- 1/27
January 28, 2023
Markets were pushing hard to continue the rally as.recession fears and layoff announcements offset two data points that suggest inflation may be easing
Via
MarketBeat
Topics
Economy
Workforce
Exposures
Economy
Interest Rates
Layoff
How Could GSK's RSV Vaccine Change its Valuation?
January 26, 2023
GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future.
Via
MarketBeat
Exposures
Product Safety
Is the Pain Over for Baudax Bio Investors after a 70% Spike?
January 25, 2023
Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.
Via
MarketBeat
A Comprehensive Study Exploring Balantidiasis Market : Key Players Fougera Pharmaceuticals, Medtronic, NuVasive
January 24, 2023
Get Balantidiasis Market analysis, key vendors & competitive scenario of the market prepared using market research tools such as Porter’s five forces and SWOT analysis.
Via
SBWire
When Does Pfizer Become A Bargain?
January 23, 2023
With a price-to-earnings ratio of less than 9 and a dividend yield of 3.63% you have to be thinking that Pfizer may a bit of a bargain down here.
Via
MarketBeat
Exposures
COVID-19
Tumor Lysis Syndrome Market Projected to Show Strong Growth : AbbVie, Hikma Pharmaceuticals, Amgen, Genentech
January 23, 2023
Get an extensive Tumor Lysis Syndrome Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
Is C3.ai Stock a ChatGPT Artificial Intelligence Play?
January 23, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Moderna and Pfizer Race to Release RSV Vaccines
January 19, 2023
Two of the largest vaccine producers have engaged in the rapid development of RSV vaccines, here's how the companies are tracking so far.
Via
MarketBeat
Exposures
Product Safety
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via
MarketBeat
Drug Delivery Market – Major Technology Giants in Buzz Again : Johnson & Johnson, Sanofi, Pfizer
January 18, 2023
How to reach that market place and its associated audience with current marketing efforts? Benchmark now the competitive efforts with high growth emerging players and leaders of Drug Delivery Market.
Via
SBWire
Health and Beauty Products Market to Eyewitness Massive Growth by 2028 : Wallgreen, Coty, Nestle
January 18, 2023
Stay up-to-date with Health and Beauty Products Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
January 18, 2023
Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries
January 17, 2023
From
Pfizer Inc.
Via
Business Wire
"CDC, FDA…link between Pfizer's shot & strokes" 2 years after FDA warning; Media Failing US: Expert
January 15, 2023
January 15, 2023 -- FDA's warning of death, strokes, and serious reactions from the shot posted at https://www.fda.gov/media/143557/download pg 16 Oct 22, 2020 were never reported by media, says...
Via
24-7 Press Release
Exposures
Product Safety
Direct to Consumer Pharmaceutical Advertising Market Is Going to Boom : Pfizer, Merck, GlaxoSmithKline
January 11, 2023
Stay up-to-date with Direct To Consumer Pharmaceutical Advertising Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.
Via
SBWire
Atypical Digital, A Global Digital Marketing Tech Enabled Company, acquires South Korea-based Springworks
January 10, 2023
Via
AB Newswire
Four Undervalued Healthcare Stocks for 2023
January 06, 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc.
Via
MarketBeat
Exposures
COVID-19
A Comprehensive Study Exploring Nephroblastoma Treatment Market: Key Players Bayer HealthCare, Pfizer, AstraZeneca
January 06, 2023
Get an extensive Nephroblastoma Treatment Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.
Via
SBWire
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children
January 06, 2023
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.